Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for Cognitive and Circadian Dysfunction in Bipolar Disorder
NCT01965925Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jan 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of modafinil in bipolar disorder (BD), sponsored by Icahn School of Medicine at Mount Sinai. Started Jan 2014; status: completed.
02
Drugs
modafinil
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01965925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01965925.